Medicare Enrolled

Dr. Raymond Garcia, MD

Addiction Medicine (Psychiatry & Neurology) Physician · Rockford, IL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
8616 NORTHERN AVE, Rockford, IL 61107
8153999700
In practice since 2005 (20 years)
NPI: 1245217959 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Garcia from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Garcia? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Garcia

Dr. Raymond Garcia is an addiction medicine physician in Rockford, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Garcia performed 175 Medicare services across 84 unique beneficiaries.

Between the years covered by Open Payments, Dr. Garcia received a total of $13,016 from 43 pharmaceutical and/or device companies across 669 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in addiction medicine (psychiatry & neurology) physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Garcia is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 175 Medicare services $13,016 industry payments

Medicare Practice Summary

Medicare Utilization ↗
175
Medicare services
Bottom 46% in IL for addiction medicine (psychiatry & neurology) physician
84
Unique beneficiaries
$81
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~9 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
 124 $85 $205
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
 36 $64 $138
Psychiatric diagnostic evaluation with medical services
A psychiatric assessment that includes medical services to evaluate mental health conditions.
 15 $94 $678
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$13,016
Total received (2018-2024)
Avg $1,859/year across 7 years
Top 21% in IL for addiction medicine (psychiatry & neurology) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
669
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,016 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,813
2023
$3,142
2022
$1,902
2021
$1,260
2020
$1,011
2019
$1,218
2018
$671

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$504
ABBVIE INC.
$474
Teva Pharmaceuticals USA, Inc.
$381
Axsome Therapeutics, Inc.
$320
Lundbeck LLC
$295
IRONSHORE PHARMACEUTICALS INC.
$278
Neurocrine Biosciences, Inc.
$263
Supernus Pharmaceuticals, Inc.
$244
Otsuka America Pharmaceutical, Inc.
$237
LivaNova USA, Inc.
$171
Alkermes, Inc.
$151
Corium, LLC
$105
Braeburn Inc.
$86
Vanda Pharmaceuticals Inc.
$83
Janssen Pharmaceuticals, Inc
$74
IDORSIA PHARMACEUTICALS US INC
$49
Takeda Pharmaceuticals U.S.A., Inc.
$46
E.R. Squibb & Sons, L.L.C.
$37
Otsuka Pharmaceutical Development & Commercialization, Inc.
$16
Top 3 companies account for 35.6% of 2024 payments
All-time payments by company (2018-2024) ›
Otsuka America Pharmaceutical, Inc.
$1,759
Lundbeck LLC
$1,257
Neurocrine Biosciences, Inc.
$1,009
Teva Pharmaceuticals USA, Inc.
$915
ABBVIE INC.
$807
Vanda Pharmaceuticals Inc.
$709
Janssen Pharmaceuticals, Inc
$655
Alkermes, Inc.
$587
ITI, Inc.
$543
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$504
Axsome Therapeutics, Inc.
$497
Takeda Pharmaceuticals U.S.A., Inc.
$467
Supernus Pharmaceuticals, Inc.
$455
Corium, LLC
$350
IRONSHORE PHARMACEUTICALS INC.
$278
LivaNova USA, Inc.
$244
Indivior Inc.
$222
Sunovion Pharmaceuticals Inc.
$206
Adlon Therapeutics L.P.
$196
Braeburn Inc.
$128
Ironshore Pharmaceuticals Inc.
$127
Shire North American Group Inc
$102
Allergan, Inc.
$100
Allergan Inc.
$96
Vertical Pharmaceuticals, LLC
$90
Brainsway USA INC
$86
Eisai Inc.
$80
IDORSIA PHARMACEUTICALS US INC
$69
Almatica Pharma LLC
$57
Neuronetics, Inc.
$50
Orexo US, Inc.
$48
Merck Sharp & Dohme LLC
$45
Bausch Health US, LLC
$42
USWM, LLC
$40
E.R. Squibb & Sons, L.L.C.
$37
BioXcel Therapeutics, Inc.
$35
AbbVie Inc.
$31
Merck Sharp & Dohme Corporation
$29
Otsuka Pharmaceutical Development & Commercialization, Inc.
$16
ACADIA Pharmaceuticals Inc
$16
EISAI INC.
$13
Jazz Pharmaceuticals Inc.
$12
OWP Pharmaceuticals, Inc.
$8
Top 3 companies account for 30.9% of all-time payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ABILIFY MAINTENA · ABILIFY MYCITE · ADHANSIA XR · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Austedo XR · Auvelity · Azstarys · BELSOMRA · BRINTELLIX · BRIXADI · Brainsway Deep TMS · CAPLYTA · CITALOPRAM · COBENFY · Dayvigo · FANAPT · Fanapt · GRALISE · HETLIOZ · Hetlioz · IGALMI · INGREZZA · INVEGA SUSTENNA · INVEGA TRINZA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · LOREEV XR · LYBALVI · Lucemyra · METHYLPHENIDATE 72 · MYDAYIS · NEUROSTAR TMS THERAPY · NUPLAZID · PERSERIS · QELBREE · QUVIVIQ · Qelbree · REJOYN · RELEXXII · REXULTI · SPRAVATO · SUBLOCADE · SUBVENITE · SUNOSI · SYMJEPI · TRINTELLIX · Trintellix · UZEDY · VIVITROL · VNS THERAPY SYMMETRY MODEL 8103 GENERATOR · VNS Therapy Symmetry Model 8103 Generator · VRAYLAR · VYVANSE · Vivitrol · Vivitrol 380 mg · Zubsolv
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an addiction medicine physician in Rockford?
Compare addiction medicine physicians in the Rockford area by procedure volume, costs, and industry payment transparency.
Browse addiction medicine physicians nearby

Geographic Context

Addiction medicine physicians within 10 mi
1
Per 100K population
0.4
County median income
$64,363
Nearest hospital
SAINT ANTHONY MEDICAL CENTER
2.1 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Garcia is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Garcia experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Garcia performed 124 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Garcia receive payments from pharmaceutical companies?
Yes. Dr. Garcia received a total of $13,016 from 43 companies across 669 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Garcia's costs compare to other addiction medicine physicians in Rockford?
Dr. Garcia's average Medicare payment per service is $81. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Garcia) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Addiction Medicine Physicians in Rockford
Browse addiction medicine physicians in Rockford ranked by procedure volume and transparency data.
Highest volume
Top Addiction Medicine Physicians in IL
Addiction medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Addiction Medicine Physicians in IL
Which IL addiction medicine physicians receive the most from drug and device companies.
By company
Otsuka America Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Otsuka America Pharmaceutical, Inc.
By company
Lundbeck LLC Payments to Doctors
See all physicians who received payments from Lundbeck LLC.
By company
Neurocrine Biosciences, Inc. Payments to Doctors
See all physicians who received payments from Neurocrine Biosciences, Inc.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →